litlas
ログインアカウント作成

Robert C. Doebele

1994–2025 年に発表

113
論文数
29,291
被引用数
74
h 指数
112
i10 指数

被引用数

Robert C. Doebele の年別被引用数1971 年: 被引用 1 件1996 年: 被引用 3 件1998 年: 被引用 6 件1999 年: 被引用 3 件2000 年: 被引用 5 件2001 年: 被引用 2 件2002 年: 被引用 6 件2003 年: 被引用 2 件2004 年: 被引用 7 件2005 年: 被引用 9 件2006 年: 被引用 6 件2007 年: 被引用 3 件2008 年: 被引用 1 件2009 年: 被引用 2 件2010 年: 被引用 5 件2011 年: 被引用 28 件2012 年: 被引用 107 件2013 年: 被引用 170 件2014 年: 被引用 163 件2015 年: 被引用 232 件2016 年: 被引用 292 件2017 年: 被引用 315 件2018 年: 被引用 423 件2019 年: 被引用 1,443 件2020 年: 被引用 1,837 件2021 年: 被引用 1,729 件2022 年: 被引用 1,409 件2023 年: 被引用 896 件2024 年: 被引用 1,272 件2025 年: 被引用 600 件2026 年: 被引用 18 件1972〜1995 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,947 件、この内訳の 25.3%中国: 引用元論文 1,644 件、この内訳の 14.1%イタリア: 引用元論文 739 件、この内訳の 6.3%イギリス: 引用元論文 559 件、この内訳の 4.8%ドイツ: 引用元論文 545 件、この内訳の 4.7%日本: 引用元論文 535 件、この内訳の 4.6%フランス: 引用元論文 498 件、この内訳の 4.3%カナダ: 引用元論文 391 件、この内訳の 3.4%スペイン: 引用元論文 386 件、この内訳の 3.3%スイス: 引用元論文 341 件、この内訳の 2.9%オランダ: 引用元論文 306 件、この内訳の 2.6%韓国: 引用元論文 297 件、この内訳の 2.5%
0%25.3%その他 21.2%

機関

分野

  • Medicine72.8%
  • Biochemistry, Genetics and Molecular Biology21.3%
  • Immunology and Microbiology2.1%
  • Chemistry0.7%
  • Computer Science0.6%
  • Physics and Astronomy0.5%
  • その他2%

トピック

  • Lung Cancer Treatments and Mutations14.7%
  • Cancer Genomics and Diagnostics6.4%
  • Lung Cancer Research Studies6.3%
  • Lung Cancer Diagnosis and Treatment5.4%
  • Cancer Immunotherapy and Biomarkers4.8%
  • Colorectal Cancer Treatments and Studies1.9%
  • その他60.5%

共著者

全論文

検索で開く
  1. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

    著者: Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares, Salvatore Siena, Alice T. Shaw, Anna F. Farago, Collin M. Blakely, Takashi Seto, Byoung Chul Cho, Diégo Tosi, Benjamin Besse, Sant P. Chawla, Lyudmila Bazhenova, John C. Krauss, Young Kwang Chae, Minal Barve, Ignacio Garrido‐Laguna, Stephen V. Liu, Paul Conkling, Thomas John, Marwan Fakih, Darren Sigal, Herbert H. Loong, Gary L. Buchschacher, Pilar Garrido, Jorgé Nieva, Conor Steuer, Tobias R. Overbeck, Daniel W. Bowles, Elizabeth Fox, Todd Riehl, Edna Chow‐Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, George D. Demetri - The Lancet Oncology 2019 被引用: 1,744

  2. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children

    著者: Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar, Steven G. DuBois, Ulrik Lassen, George D. Demetri, Michael J. Nathenson, Robert C. Doebele, Anna F. Farago, Alberto S. Pappo, Brian Turpin, Afshin Dowlati, Marcia S. Brose, Leo Mascarenhas, Noah Federman, Jordan Berlin, Wafik S. El‐Deiry, Christina S. Baik, John F. Deeken, Valentina Boni, Ramamoorthy Nagasubramanian, Matthew H. Taylor, Erin R. Rudzinski, Funda Meric‐Bernstam, Davendra Sohal, C. Patrick, Luis E. Raez, Jaclyn F. Hechtman, Ryma Benayed, Marc Ladanyi, Brian B. Tuch, Kevin Ebata, Scott Cruickshank, Nora Ku, Michael C. Cox, Douglas S. Hawkins, David S. Hong, David M. Hyman - New England Journal of Medicine 2018 被引用: 2,728

  3. Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

    著者: Ashley Maynard, Caroline E. McCoach, Julia Rotow, Lincoln Harris, Franziska Haderk, D. Lucas Kerr, Elizabeth A. Yu, Erin L. Schenk, Weilun Tan, Alexander Zee, Michelle Tan, Philippe Gui, Tasha Lea, Wei Wu, Anatoly Urisman, Kirk D. Jones, Rene Sit, K. Kolli, Eric J. Seeley, Yaron Gesthalter, Daniel D. Le, Kevin A. Yamauchi, David M. Naeger, Sourav Bandyopadhyay, Khyati N. Shah, Lauren Čech, Nicholas J. Thomas, Anshal Gupta, Mayra Gonzalez, Hien Do, Lisa Tan, Bianca Bacaltos, Rafael Gómez-Sjöberg, Matthew A. Gubens, Thierry Jahan, Johannes R. Kratz, David M. Jablons, Norma Neff, Robert C. Doebele, Jonathan S. Weissman, Collin M. Blakely, Spyros Darmanis, Trever G. Bivona - Cell 2020 被引用: 722

  4. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    著者: Daniel R. Gomez, Chad Tang, Jianjun Zhang, George R. Blumenschein, Mike Hernández, J. Jack Lee, Rong Ye, David A. Palma, Alexander V. Louie, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, James W. Welsh, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Anne S. Tsao, Boris Sepesi, Stephen G. Swisher, John V. Heymach - Journal of Clinical Oncology 2019 被引用: 1,270

  5. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

    著者: Justin F. Gainor, Giuseppe Curigliano, Dong‐Wan Kim, Ki Hyeong Lee, Benjamin Besse, Christina S. Baik, Robert C. Doebele, Philippe A. Cassier, Gilberto Lopes, Daniel S.W. Tan, Elena Garralda, Luis Paz‐Ares, Byoung Chul Cho, Shirish M. Gadgeel, Michael Thomas, Stephen V. Liu, Matthew H. Taylor, Aaron S. Mansfield, Viola W. Zhu, Corinne Clifford, Hui Zhang, Michael Palmer, Jennifer Green, Christopher D. Turner, Vivek Subbiah - The Lancet Oncology 2021 被引用: 443

  6. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

    著者: Alice T. Shaw, Sai‐Hong Ignatius Ou, Yung‐Jue Bang, D. Ross Camidge, Benjamin Solomon, Ravi Salgia, Gregory J. Riely, Marileila Varella‐Garcia, Geoffrey I. Shapiro, Daniel B. Costa, Robert C. Doebele, Long P. Le, Zongli Zheng, Weiwei Tan, Patricia Stephenson, S. Martin Shreeve, L. Tye, James G. Christensen, Keith D. Wilner, Jeffrey W. Clark, A. John Iafrate - New England Journal of Medicine 2014 被引用: 1,993

  7. Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations

    著者: Alexander Drilon, Sai‐Hong Ignatius Ou, Byoung Chul Cho, Dong‐Wan Kim, Jeeyun Lee, Jessica J. Lin, Viola W. Zhu, Myung‐Ju Ahn, D. Ross Camidge, Judy Nguyen, Dayong Zhai, Wei Deng, Zhongdong Huang, Evan Rogers, Juliet Liu, Jeff Whitten, John K. C. Lim, Shanna Stopatschinskaja, David M. Hyman, Robert C. Doebele, J. Jean Cui, Alice T. Shaw - Cancer Discovery 2018 被引用: 480

  8. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    著者: Daniel R. Gomez, George R. Blumenschein, J Jack Lee, Mike Hernández, Rong Ye, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Chad Tang, Ritsuko Komaki, Alexander V. Louie, David A. Palma, Anne S. Tsao, Boris Sepesi, William N. William, Jianjun Zhang, Qiuling Shi, Xin Shelley Wang, Stephen G. Swisher, John V. Heymach - The Lancet Oncology 2016 被引用: 1,086

  9. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

    著者: Alexander Drilon, Salvatore Siena, Rafał Dziadziuszko, Fabrice Barlési, Matthew Krebs, Alice T. Shaw, Filippo de Braud, Christian Rolfo, Myung‐Ju Ahn, Jürgen Wolf, Takashi Seto, Byoung Chul Cho, Manish R. Patel, Chao‐Hua Chiu, Thomas John, Kōichi Goto, Christos S. Karapetis, Hendrick-Tobias Arkenau, Sang-We Kim, Yuichiro Ohe, Yu Li, Young Kwang Chae, Christine H. Chung, Gregory A. Otterson, Haruyasu Murakami, Chia‐Chi Lin, Daniel Shao-Weng Tan, Hans Prenen, Todd Riehl, Edna Chow‐Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, Robert C. Doebele - The Lancet Oncology 2019 被引用: 537

  10. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC

    著者: D. Ross Camidge, Robert C. Doebele, Keith M. Kerr - Nature Reviews Clinical Oncology 2019 被引用: 559

  11. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)

    著者: Alexander Drilon, Salvatore Siena, Sai‐Hong Ignatius Ou, Manish R. Patel, Myung‐Ju Ahn, Jeeyun Lee, Todd M. Bauer, Anna F. Farago, Jennifer J. Wheler, Stephen V. Liu, Robert C. Doebele, Laura Giannetta, Giulio Cerea, Giovanna Marrapese, Michele Schirru, Alessio Amatu, Katia Bencardino, Laura Palmeri, Andrea Sartore‐Bianchi, Angelo Vanzulli, Sara Cresta, Silvia Damian, Matteo Duca, Elena Ardini, Gang Li, Jason Christiansen, Karey Kowalski, Ann Johnson, Rupal Patel, David Luo, Edna Chow‐Maneval, Zachary Hornby, Pratik S. Multani, Alice T. Shaw, Filippo de Braud - Cancer Discovery 2017 被引用: 817

  12. Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

    著者: Jacqulyne Robichaux, Yasir Y. Elamin, Zhi Tan, Brett W. Carter, Shuxing Zhang, Shengwu Liu, Shuai Li, Ting Chen, Alissa Poteete, Adriana Estrada‐Bernal, Anh T. Le, Anna Truini, Monique B. Nilsson, Huiying Sun, Emily Roarty, Sarah B. Goldberg, Julie R. Brahmer, Mehmet Altan, Charles Lu, Vassiliki A. Papadimitrakopoulou, Katerina Politi, Robert C. Doebele, Kwok‐Kin Wong, John V. Heymach - Nature Medicine 2018 被引用: 455

  13. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, M.C. Dobelbower, Robert C. Doebele, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Leah J. Leisch, Rogerio Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2017 被引用: 1,325

  14. Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC

    著者: Alexander Drilon, Chao‐Hua Chiu, Yun Fan, Byoung Chul Cho, Shun Lü, Myung‐Ju Ahn, Matthew Krebs, Stephen V. Liu, Thomas John, Gregory A. Otterson, Daniel S.W. Tan, Tejas Patil, Rafał Dziadziuszko, Erminia Massarelli, Takashi Seto, Robert C. Doebele, Bethany Pitcher, Nino Kurtsikidze, Sebastian Heinzmann, Salvatore Siena - JTO Clinical and Research Reports 2022 被引用: 113

  15. TRKing Down an Old Oncogene in a New Era of Targeted Therapy

    著者: Aria Vaishnavi, Anh‐Tuan Le, Robert C. Doebele - Cancer Discovery 2014 被引用: 644

  16. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers

    著者: Collin M. Blakely, Thomas B.K. Watkins, Wei Wu, Beatrice Gini, Jacob J. Chabon, Caroline E. McCoach, Nicholas McGranahan, Gareth A. Wilson, Nicolai J. Birkbak, Victor Olivas, Julia Rotow, Ashley Maynard, Victoria Wang, Matthew A. Gubens, Kimberly C. Banks, Richard B. Lanman, Aleah F. Caulin, John St. John, Anibal R. Cordero, Petros Giannikopoulos, Andrew D. Simmons, Philip C. Mack, David R. Gandara, Hatim Husain, Robert C. Doebele, Jonathan W. Riess, Maximilian Diehn, Charles Swanton, Trever G. Bivona - Nature Genetics 2017 被引用: 578

  17. A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas

    著者: Mrinal M. Gounder, Todd M. Bauer, Gary K. Schwartz, Amy Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G. Tirunagaru, Feng Xu, Robert C. Doebele, David S. Hong - Journal of Clinical Oncology 2023 被引用: 91

  18. The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

    著者: Tejas Patil, Derek Smith, Paul A. Bunn, Dara L. Aisner, Anh T. Le, Mark J. Hancock, W. Thomas Purcell, Daniel W. Bowles, D. Ross Camidge, Robert C. Doebele - Journal of Thoracic Oncology 2018 被引用: 199

  19. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    著者: Andrew Weickhardt, Benjamin Scheier, Joseph Burke, Gregory N. Gan, Xian Lu, Paul A. Bunn, Dara L. Aisner, Laurie E. Gaspar, Brian D. Kavanagh, Robert C. Doebele, D. Ross Camidge - Journal of Thoracic Oncology 2012 被引用: 677

  20. Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or MetastaticROS1Fusion–Positive Non–Small-Cell Lung Cancer

    著者: Rafał Dziadziuszko, Matthew Krebs, Filippo de Braud, Salvatore Siena, Alexander Drilon, Robert C. Doebele, Manish Patel, Byoung Chul Cho, Stephen V. Liu, Myung‐Ju Ahn, Chao‐Hua Chiu, Anna F. Farago, Chia‐Chi Lin, Christos S. Karapetis, Yu Li, Bann‐Mo Day, David Chen, Timothy R. Wilson, Fabrice Barlési - Journal of Clinical Oncology 2021 被引用: 156

  21. Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

    著者: Kurtis D. Davies, Anh T. Le, Mariana F. Theodoro, Margaret C. Skokan, Dara L. Aisner, Eamon M. Berge, Luigi Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli, Marco Alloisio, Armando Santoro, D. Ross Camidge, Marileila Varella‐Garcia, Robert C. Doebele - Clinical Cancer Research 2012 被引用: 472

  22. HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib

    著者: Y. Wang, Tao Jiang, Zhen Qin, Jinghui Jiang, Qiang Wang, Seung Hee Yang, Christopher J. Rivard, G. Gao, Tony L. Ng, Megan M. Tu, Hui Yu, Huiping Ji, Caicun Zhou, Shengxiang Ren, Jun Zhang, Paul A. Bunn, Robert C. Doebele, D. Ross Camidge, Fred R. Hirsch - Annals of Oncology 1999 被引用: 217

  23. Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non–small Cell Lung Cancer

    著者: Caroline E. McCoach, Anh T. Le, Katherine Gowan, Kenneth A. Jones, Laura Schubert, Andrea E. Doak, Adriana Estrada‐Bernal, Kurtis D. Davies, Daniel T. Merrick, Paul A. Bunn, W. Tom Purcell, Rafał Dziadziuszko, Marileila Varella‐Garcia, Dara L. Aisner, D. Ross Camidge, Robert C. Doebele - Clinical Cancer Research 2018 被引用: 246

  24. Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

    著者: David S. Hong, Todd M. Bauer, J.J. Lee, Afshin Dowlati, Marcia S. Brose, Anna F. Farago, Matthew H. Taylor, Alice T. Shaw, Sandra Montez, Funda Meric‐Bernstam, Steven G. Smith, Brian B. Tuch, Kevin Ebata, Scott Cruickshank, M.C. Cox, Howard A. Burris, Robert C. Doebele - Annals of Oncology 2019 被引用: 153